Lantheus Holdings (LNTH) Other Non Operating Income (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Other Non Operating Income came in at $5.7 million in Q1 2026, up 7420.51% year-on-year from $75925.7 in Q1 2025, and up 1901.26% on a QoQ basis from -$317000.0 in Q4 2025.

Lantheus Holdings (LNTH) Other Non Operating Income (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Other Non Operating Income data on file, last reported at $5.7 million in Q1 2026.

  • On a quarterly basis, Other Non Operating Income rose 7420.51% year-over-year to $5.7 million in Q1 2026; TTM through Mar 2026 was $4.8 million, a 2188.21% increase from a year earlier, with the FY2025 full-year figure at -$1.0 million, down 1624.24% from the prior year.
  • Other Non Operating Income for Q1 2026 stood at $5.7 million, up from -$317000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for LNTH reached as high as $52.6 million in Q3 2023 and fell as low as -$58.2 million in Q4 2023.
  • Historically, Other Non Operating Income has averaged $856058.8 across 5 years, with a median of $46000.0 in 2024.
  • Across the five-year window, Other Non Operating Income sank 9607.33% in 2023 and soared 7420.51% in 2026, its largest moves.
  • Year by year, Other Non Operating Income stood at -$600000.0 in 2022, then sank by 9607.33% to -$58.2 million in 2023, then jumped by 100.44% to $258000.0 in 2024, then sank by 222.87% to -$317000.0 in 2025, then soared by 1901.26% to $5.7 million in 2026.
  • Per Business Quant data, the three most recent Other Non Operating Income figures were $5.7 million in Q1 2026, -$317000.0 in Q4 2025, and -$269000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.71 Mn
Dec 31, 2025 -317,000.00
Sep 30, 2025 -269,000.00
Jun 30, 2025 -342,000.00
Mar 31, 2025 -78,000.00
Dec 31, 2024 258,000.00
Sep 30, 2024 46,000.00
Jun 30, 2024 -455,000.00
Mar 31, 2024 8.79 Mn
Dec 31, 2023 -58.24 Mn
Sep 30, 2023 52.65 Mn
Jun 30, 2023 4.48 Mn
Mar 31, 2023 3.23 Mn
Dec 31, 2022 -600,000.00
Sep 30, 2022 -1.10 Mn
Jun 30, 2022 310,000.00
Mar 31, 2022 485,000.00
Sep 30, 2021 -3.94 Mn
Jun 30, 2021 182,000.00
Mar 31, 2021 900,000.00